COMMUNIQUÉS West-GlobeNewswire

Aran Biomedical Pioneers breakthrough medical textiles valve covering technology; ValvTEX™

13/11/2018 - 10:42

GALWAY, Ireland, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Aran Biomedical, a trusted partner in design, development and manufacture of implantable medical devices, today announced its new medical textile valve covering [...]

AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update

13/11/2018 - 10:01

Announced important clinical milestones for ACI-24 vaccine in Alzheimer's disease and Down Syndrome Company record high, period end cash position of approximately CHF 200 million that is expected to extend our cash [...]

LIDDS receives approval from MPA to start Phase I study NZ-DTX-001

13/11/2018 - 08:45

The Swedish Medical Product Agency has approved a first-in-human study, NZ-DTX-001, in which solid tumors will be treated with NanoZolid combined with docetaxel. This is LIDDS' second clinical project and will initially [...]

Ambu A/S: Annual Report 2017/18 (Earnings release)

13/11/2018 - 08:02

Ambu ends the year with 15% organic growth and an EBIT margin of 21.6%. Following a 2.5 percentage point EBIT margin increase, Ambu is on track to realising the targets of its 2020 strategy. "We have now come to the end [...]

PCI Biotech: Third quarter 2018 results

13/11/2018 - 07:30

Oslo (Norway), 13 November 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim third quarter 2018 result. Please find enclosed the report and presentation. The fully [...]

Kiadis Pharma to present at upcoming investor conferences in November 2018

13/11/2018 - 07:01

Kiadis Pharma to present at upcoming investor conferences in November 2018 Amsterdam, The Netherlands, November 13, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a [...]

Nightstar Announces Planned Initiation of Phase 2/3 Expansion Study in XIRIUS Trial for NSR-RPGR in XLRP and Reports Third Quarter 2018 Financial Results

13/11/2018 - 07:00

Phase 2/3 Expansion Study to Include No-Sham Control Arm in Alignment with FDA Draft Guidance on Development of Gene Therapy Products for Retinal Disorders Preliminary Efficacy Data from Phase 2/3 Expansion Study [...]

Sharecare and Gallup announce 2017 state and community rankings for diabetes prevalence

13/11/2018 - 06:01

Zero U.S. states lower obesity and diabetes rates in ten-year period ATLANTA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company that helps people manage all their health in one place, and world- [...]

First quantitative diagnostic test validated for Treatment-Free Remission for Eligible Patients with Ph+ CML-CP Treated with Tasigna® Cleared by Health Canada

13/11/2018 - 06:00

PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- MolecularMD Corporation received regulatory approval from Health Canada for the MRDx ® BCR-ABL Test, a quantitative diagnostic test used as an aid [...]

CORRECTION: Unum Therapeutics to Host Investor Event on its Efforts to Realize the Promise of T Cell Therapies in Solid Tumors

13/11/2018 - 00:13

CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Unum Therapeutics Inc. (NASDAQ: UMRX), please note the investors event date has been changed from November [...]

Corizon Health Launches Dedicated Military Recruiting Team

12/11/2018 - 23:57

BRENTWOOD, Tenn., Nov. 12, 2018 (GLOBE NEWSWIRE) -- In recognition of Veteran’s Day, Corizon Health today announced creation of a recruiting team dedicated to bringing US military veterans into its healthcare ranks. “ [...]

TOMI Environmental Solutions, Inc. to Hold Third Quarter 2018 Financial Results Conference Call on Monday, November 19, 2018

12/11/2018 - 23:01

BEVERLY HILLS, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]

Eton Pharmaceuticals Announces Pricing of Initial Public Offering

12/11/2018 - 22:52

DEER PARK, Ill., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced the [...]

DiaMedica Therapeutics Has Applied to List its Common Shares on Nasdaq, Announces Share Consolidation

12/11/2018 - 22:45

MINNEAPOLIS, Nov. 12, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSX Venture:DMA) (OTCQB:DMCAF), a clinical stage biopharmaceutical company, announced today that it has applied to list its common shares on [...]

Zomedica Pharmaceuticals Corp. to Present at Jefferies 2018 London Healthcare Conference and LD Micro Main Event XI

12/11/2018 - 22:30

ANN ARBOR, Mich., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the [...]

Kane Biotech Announces Extension of Warrants

12/11/2018 - 22:30

WINNIPEG, Manitoba, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) , today announced that it has amended the terms of its 34,504,997 common share [...]

WW to Present at Morgan Stanley Global Consumer & Retail Conference

12/11/2018 - 22:30

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WTW) (“WW”), a global wellness company and the world’s leading commercial weight management program, today announced that Mindy [...]

ERYTECH Reports Third Quarter 2018 Financial Results and Provides Business Update

12/11/2018 - 22:30

Conference call and webcast scheduled for Tuesday, November 13 at 14:30 CET/8:30 am EST Phase 3 trial for eryaspase in second line pancreatic cancer enrolling patients Phase 2 trial in triple-negative breast cancer to [...]

ERYTECH publie ses résultats financiers du troisième trimestre 2018 et fait le point sur son activité

12/11/2018 - 22:30

Conférence téléphonique et webcast : mardi 13 novembre à 14h30 Recrutement en cours dans l’étude de phase 3 avec eryaspase dans le traitement en seconde ligne du cancer du pancréas Début du recrutement dans l’étude de [...]